4//SEC Filing
Arenberg Michael 4
Accession 0001567619-22-022096
CIK 0001623715other
Filed
Dec 28, 7:00 PM ET
Accepted
Dec 29, 4:06 PM ET
Size
12.8 KB
Accession
0001567619-22-022096
Insider Transaction Report
Form 4
Arenberg Michael
See Remarks
Transactions
- Exercise/Conversion
Common Stock
2022-12-27$18.44/sh+66,794$1,231,681→ 119,895 total - Exercise/Conversion
Common Stock
2022-12-27$15.45/sh+28,206$435,783→ 53,101 total - Sale
Common Stock
2022-12-27$35.93/sh−70,508$2,533,352→ 49,387 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-12-27−28,206→ 2,149 totalExercise: $15.45From: 2022-12-15Exp: 2032-11-07→ Common Stock (28,206 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2022-12-27−66,794→ 304,206 totalExercise: $18.44From: 2022-12-15Exp: 2032-03-22→ Common Stock (66,794 underlying)
Footnotes (1)
- [F1]The transaction was executed in multiple trades in prices ranging from $35.93 to $35.935, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Documents
Issuer
Imago BioSciences, Inc.
CIK 0001623715
Entity typeother
Related Parties
1- filerCIK 0001755509
Filing Metadata
- Form type
- 4
- Filed
- Dec 28, 7:00 PM ET
- Accepted
- Dec 29, 4:06 PM ET
- Size
- 12.8 KB